Bionomics is a drug discovery and development company focused on new treatments for cancer and serious disorders of the central nervous system (CNS). The company utilizes its technology platforms with the aim of identifying and developing therapies to treat cancer and conditions of the CNS, including anxiety, multiple sclerosis and epilepsy. In September 2012, BMICY acquired Eclipse Therapeutics Inc. For further information, visit the company’s Web site at www.bionomics.com/au

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: